Packages that provide differentiation, counterfeit meds, sustainability, temperature-sensitive shipments, regulatory and FDA issues, and serialization capture the eyes and minds of Healthcare Packaging Web site viewers. From 10 to 1, here's the skinny on the most-viewed articles during 2010.
10. Pfizer's European study reveals disturbing counterfeit news
In this aggregate news item, BusinessWeek.com reports that illegal medicine sales in Europe top $14 billion annually, with one in five Europeans saying they've purchased prescription drugs through the Internet, without a doctor's guidance.
9. New frontier emerging in use of packaging to differentiate pharmaceuticals
The time has come to view packaging as more than just a container, but a value-added element that can improve patient outcomes and offer on-shelf differentiation for pharmaceutical manufacturers. MeadWestvaco's Joel Beckerman and Julia Amadio both agree it's time for pharmaceutical manufacturers to ask more from their primary and secondary packaging in the healthcare sector.
8. Sustainability growing as a medical device packaging concern
Maintaining a sterile barrier from manufacturing through the last mile to the patient is and will remain a top priority for medical device makers. But ready or not, sustainability is becoming a more significant factor.
Designers may carry the burden of developing 'greener' medical devices and packaging to help offset hospital waste and increased environmental concerns.
7. Eli Lilly's insulin kit delivers innovation, information
An innovative new kit developed by Eli Lilly and Co. and Group 4 incorporates package design to address the issues faced by new insulin users.
6. Monitoring distribution is critical for temperature-sensitive shipments
In this 'Voice of the Experts' Q&A, Healthcare Packaging talks with Dan Gagnon, director, Healthcare Logistics Strategy Group, UPS, about distribution factors, regulatory issues, and trends in temperature-sensitive shipping.
5. Regulations and standards to lead pharmaceutical packaging sales
A Freedonia report, "Pharmaceutical Packaging," explains that an increased focus on regulatory and other issues will drive growth for container accessories, especially parenteral vials and flip-top closures, plastic dispensing bottles and closures, prefillable inhalers and syringes, track-and-trace and authentication labels, and unit-dose pouches.
4. How to avoid and respond to FDA 483 letters
This 10-step guide is designed to help pharmaceutical processors, blood and tissue banks, clinical laboratories, medical device manufacturers, research hospitals, and other GxP facilities that may receive public criticism warning letters respond quickly and appropriately within the permitted 15-day window. Proper FDA 483 letter response is critical to both help in reputation repair and for remediation actions to assure a quality process and patient safety.
3. Packaging, medical devices critical to emergency room procedures
HealthPack 2010 conference sessions report that packages, devices must work in life-or-death situations. Meanwhile, ER nurses evaluate medical device packages.
2. P&G optimizes shelf-ready packaging
Packaging professionals at P&G's Schwalbach, Germany, help the company launch a shelf-ready package for primary packages of Alldays and Always feminine care products. As a replacement for a more traditional corrugated RSC, the new tray and hood costs less, performs better, and racks up some impressive gains both in efficiency and in sustainability.
1. Europe shows the way to pharmaceutical serialization
A Q&A between Healthcare Packaging and Cognex representatives Robb Robles and Kris Bierbaum explores serialization and anti-counterfeiting from a global perspective. Through government regulations and/or standards organizations, Europe is out in front when it comes to serialization in pharmaceutical and medical device packaging applications.
10. Pfizer's European study reveals disturbing counterfeit news
In this aggregate news item, BusinessWeek.com reports that illegal medicine sales in Europe top $14 billion annually, with one in five Europeans saying they've purchased prescription drugs through the Internet, without a doctor's guidance.
9. New frontier emerging in use of packaging to differentiate pharmaceuticals
The time has come to view packaging as more than just a container, but a value-added element that can improve patient outcomes and offer on-shelf differentiation for pharmaceutical manufacturers. MeadWestvaco's Joel Beckerman and Julia Amadio both agree it's time for pharmaceutical manufacturers to ask more from their primary and secondary packaging in the healthcare sector.
8. Sustainability growing as a medical device packaging concern
Maintaining a sterile barrier from manufacturing through the last mile to the patient is and will remain a top priority for medical device makers. But ready or not, sustainability is becoming a more significant factor.
Designers may carry the burden of developing 'greener' medical devices and packaging to help offset hospital waste and increased environmental concerns.
7. Eli Lilly's insulin kit delivers innovation, information
An innovative new kit developed by Eli Lilly and Co. and Group 4 incorporates package design to address the issues faced by new insulin users.
6. Monitoring distribution is critical for temperature-sensitive shipments
In this 'Voice of the Experts' Q&A, Healthcare Packaging talks with Dan Gagnon, director, Healthcare Logistics Strategy Group, UPS, about distribution factors, regulatory issues, and trends in temperature-sensitive shipping.
5. Regulations and standards to lead pharmaceutical packaging sales
A Freedonia report, "Pharmaceutical Packaging," explains that an increased focus on regulatory and other issues will drive growth for container accessories, especially parenteral vials and flip-top closures, plastic dispensing bottles and closures, prefillable inhalers and syringes, track-and-trace and authentication labels, and unit-dose pouches.
4. How to avoid and respond to FDA 483 letters
This 10-step guide is designed to help pharmaceutical processors, blood and tissue banks, clinical laboratories, medical device manufacturers, research hospitals, and other GxP facilities that may receive public criticism warning letters respond quickly and appropriately within the permitted 15-day window. Proper FDA 483 letter response is critical to both help in reputation repair and for remediation actions to assure a quality process and patient safety.
3. Packaging, medical devices critical to emergency room procedures
HealthPack 2010 conference sessions report that packages, devices must work in life-or-death situations. Meanwhile, ER nurses evaluate medical device packages.
2. P&G optimizes shelf-ready packaging
Packaging professionals at P&G's Schwalbach, Germany, help the company launch a shelf-ready package for primary packages of Alldays and Always feminine care products. As a replacement for a more traditional corrugated RSC, the new tray and hood costs less, performs better, and racks up some impressive gains both in efficiency and in sustainability.
1. Europe shows the way to pharmaceutical serialization
A Q&A between Healthcare Packaging and Cognex representatives Robb Robles and Kris Bierbaum explores serialization and anti-counterfeiting from a global perspective. Through government regulations and/or standards organizations, Europe is out in front when it comes to serialization in pharmaceutical and medical device packaging applications.
